PUBLISHER: IMARC | PRODUCT CODE: 1792407
PUBLISHER: IMARC | PRODUCT CODE: 1792407
The global surgical robots market size reached USD 6.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 23.1 Billion by 2033, exhibiting a growth rate (CAGR) of 14.96% during 2025-2033. The growing prevalence of bone degenerative diseases, ongoing advancements in robotic technology, such as improved imaging, navigation systems, and robotic arms with greater dexterity, and rising preference for minimally invasive procedures are primarily driving the market growth.
Rising Number of Surgeries
The increasing geriatric population across the globe, who are more prone to developing chronic health conditions and surgeries is primarily driving the surgical robots market growth. Furthermore, the growing prevalence of bone degenerative diseases and the rising number of hip & knee replacement surgeries due to increasing cases of arthritis & osteoporosis are driving the global market. For instance, according to the Agency for Healthcare Research and Quality report, over 450,000 hip replacement surgeries are performed annually in the US. Additionally, according to a cardiac surgery market study by iData Research, the number of cardiac surgeries exceeds 900,000 procedures each year in the United States with projections for the number to reach 1.3 million by 2029. The rising prevalence of these conditions is leading to an increase in the number of patients requiring surgeries. Besides this, the escalating number of road accidents across the globe is also contributing to the need for efficient surgical procedures and robots. For instance, as per the report published by the Ministry of Road Transport and Highways, a total of 4,61,312 road accidents were reported by States and Union Territories (UTs) during 2022, which claimed 1,68,491 lives and caused injuries to 4,43,366 persons. This marks an increase of 11.9% in accidents, 9.4% in fatalities, and 15.3% in injuries compared to the previous year. Such a massive rise in the number of surgeries is anticipated to propel the surgical robot market demand in the coming years.
Growing Complexity of Surgical Procedures
The increasing complexity of surgical procedures and the expanding desire for minimally invasive operations with more accuracy and adaptability are further creating a positive outlook for the overall market. Moreover, robotic technology is frequently used in minimally invasive surgeries. As the name implies, these operations all involve small incisions. This technique typically leads to less pain, less blood loss, shorter hospital stays, and quicker recoveries, allowing surgeons to operate on hard-to-reach body parts and get a better view of hidden areas, encouraging patients worldwide to choose robotic surgery and growing market. Besides this, the emerging trend of cosmetic surgery to enhance the physical features of the face is also augmenting the demand for surgery robots that can carry out precise surgical procedures. For instance, RealSelf released its 2023 RealSelf Culture Report, exploring Americans' attitudes toward plastic surgery. The online survey of more than 2,000 respondents of 18 years old and older, revealed that one in four people in America had at least one cosmetic treatment or procedure and that younger generations have experienced a positive plastic surgery shift among social groups. Consequently, the rising number of complex procedures is bolstering the need for automation in the healthcare industry, which in turn will propel the surgical robots market revenue in the coming years.
Ongoing Technological Advancements
The rising technological advancements in the field of robotics are fostering a positive outlook for the overall market. The growing integration of High-definition 3D cameras to provide surgeons with a detailed view of the surgical site and the incorporation of AI algorithms to help surgical robots make real-time adjustments during surgery are some of the significant advancements in robotic surgery development. Such advancements have transformed the way healthcare operates. Moreover, various manufacturers are increasingly investing in the development of advanced robots that can perform complex surgeries with minimal pain. For instance, in March 2024, Intuitive Surgical received an FDA green light for the fifth generation of its multiport da Vinci robot, following more than a decade of research and development. The company said the da Vinci 5 system added more than 150 upgrades over its predecessor, the da Vinci Xi, which received its agency green light in 2016. It includes new controllers for surgeons that offer force feedback, designed to mimic the feel of handheld tools during a procedure. Similarly, in September 2023, US Medical Innovations (USMI) and the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) announced the launch of the new Canady Robotic AI Surgical System. It is claimed to be the world's first artificial intelligence (AI) robotic system that generates cold atmospheric plasma (CAP) and a three-dimensional non-contact bioelectric pulse electromagnetic field. CAP precisely targets and eliminates microscopic tumor cells during surgery while preserving the health of non-cancerous surrounding tissue. Such advancements are fostering a positive outlook for the market.
Instruments and accessories hold the majority of the total market share
Surgical robots use a variety of specialized instruments to perform procedures with precision and accuracy. These instruments are typically mounted on robotic arms and controlled by the surgeon using a console. Graspers, scissors, needle drivers, retractors, and suction tools are some of the common instruments found in surgical robots. Moreover, these instruments work together to enable surgeons to perform a wide range of procedures with greater precision, control, and less invasive techniques than traditional surgery.
Orthopedic surgery currently exhibits a clear dominance in the market
The increasing geriatric population across the globe, which is more prone to developing joint and muscle-related issues, is primarily driving the growth of this segment. According to the Australian Institute of Health and Welfare (AIHW) statistics, the total knee replacement rate for osteoarthritis increased by about 38% from 2005-2006 to 2017-2018. Moreover, as per the International Congress for Joint Reconstruction in March 2018, total number of primary hip replacement and knee replacement procedures is projected to reach 635,000 (171.0% increase) & 1.28 million (189.0% increase), respectively, by 2030 and 1.23 million (330.0% growth) & 2.60 million (382.0% growth) by 2060. Such a massive rise in the number of orthopedic surgeries is leading to the dominance of this segment.
Hospitals account for the largest market share
Inpatient facilities, such as hospitals, usually have the financial resources and high patient volume to justify the investment in costly surgical robotic systems. In addition, they possess the infrastructure and skilled personnel necessary to operate and maintain these advanced technologies.
North America holds the largest market share
North America holds the largest share of the global surgical robot market. The market in the region is growing due to the rising number of surgical procedures associated with colorectal and urological conditions and increasing healthcare expenditures. Moreover, in North America, the demand for General & Plastic Surgery Devices is driven by the high prevalence of cosmetic procedures and advanced healthcare infrastructure. Besides this, each year in the United States, surgeons perform approximately 64 million surgical procedures, ranging from tooth extraction to open heart surgery. Furthermore, various regional manufacturers are increasingly investing in the development of advanced surgical robots, which is creating a positive outlook for the market. For instance, in September 2024, Medtronic announced the launch of a new robot-assisted surgery platform that is more flexible and cost-effective than systems presently on the market.